NEW MEDICINAL FORM IN TREATMENT OF BRONCHIAL ASTHMA: FIXED COMBINATION OF FORMOTEROL AND BECLOMETASONE
The article describes advantages of new combined drug Foster — formoterol (6 ?g) and beclometasone) (100 ?g) in treatment of patients with bronchial asthma. It was marked that the drug is based on original delivery technology «Modulite» allowing creation an aerosol with extra fine-dispersed particle...
| প্রধান লেখক: | |
|---|---|
| বিন্যাস: | প্রবন্ধ |
| ভাষা: | English |
| প্রকাশিত: |
"Paediatrician" Publishers LLC
2010-05-01
|
| মালা: | Вопросы современной педиатрии |
| অনলাইন ব্যবহার করুন: | https://vsp.spr-journal.ru/jour/article/view/905 |